Skip to main content
Log in

Tuberculosis and HIV disease: Two decades of a dual epidemic

  • Review Article
  • Published:
Wiener Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The HIV epidemic is currently in its third decade without any sign of abating. Tuberculosis (TB) is responsible for a third of all AIDS deaths, 99% of which occur in developing countries. The two epidemics fuel each other, together making up the leading infectious causes of mortality worldwide. Tuberculosis-HIV coinfection presents special diagnostic and therapeutic challenges and constitutes an immense burden on the health care systems of heavily infected countries. Despite major gains that have been made in the past two decades, important questions still remain. To cope with the challenge of TB-HIV coinfection, further research in the design of diagnostic tests for tuberculosis, detection of drug resistantMycobacterium tuberculosis strains in HIV-positive people, as well as development of more effective therapeutic agents and vaccines are urgently needed. It has become evident that this dual epidemic will persist unless comprehensive measures are instituted through the provision of sufficient funding in addition to expanding and strengthening current control strategies adopted by governments and international organizations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dolin PJ, Raviglione MC, Kochi A (1994) Global tuberculosis incidence and mortality during 1990–2000. Bull World Health Organ 72: 213–220

    PubMed  CAS  Google Scholar 

  2. Sudre P, ten Dam G, Kochi A (1992) Tuberculosis: a global overview of the situation today. Bull World Health Organ 70: 149–159

    PubMed  CAS  Google Scholar 

  3. Centers for Disease Control and Prevention (1996) Tuberculosis morbidity — United States. 1995. MMWR Morb Mortal Rep 45: 365–370

    Google Scholar 

  4. Barnes PF, Bloch AB, Davidson PT, et al (1991) Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 324: 1644–1650

    PubMed  CAS  Google Scholar 

  5. Houston S, Ray S, Mahari P, et al (1994) The association of tuberculosis and HIV infection in Harare, Zimbabwe. Tubercle and Lung Disease 75: 220–226

    Article  PubMed  CAS  Google Scholar 

  6. Centers for Disease Control and Prevention (1995) Screening for tuberculosis and tuberculosis infection in high-risk populations. MMWR Morb Mortal Rep 44: 19–34

    Google Scholar 

  7. Alland D, Kalkut GE, Moss RA, et al (1994) Transmission of tuberculosis in New York City: an analysis by DNA finger-printing and conventional epidemiologic methods. N Engl J Med 330: 1710–1716

    Article  PubMed  CAS  Google Scholar 

  8. Braun MM, Truman BI, Maquire B, et al (1989) Increasing incidence of tuberculosis in a prison inmate population: association with HIV infection. JAMA 261: 393–397

    Article  PubMed  CAS  Google Scholar 

  9. Beck-Sague C, Dooley SW, Hutton MD, et al (1992) Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA 268: 1280

    Article  PubMed  CAS  Google Scholar 

  10. Nolan CM, Elarth AM, Barr H, et al (1991) An outbreak of tuberculosis in a shelter for homeless men: a description of its evolution and control. Am Rev Respir Dis 143: 257–261

    PubMed  CAS  Google Scholar 

  11. Brudney K, Dobkin J (1991) Resurgent tuberculosis in New York City: human immunodeficiency virus, homelesness and the decline of tuberculosis control programs. Am Rev Respir Dis 144: 745–749

    PubMed  CAS  Google Scholar 

  12. Chaulk CP, Moore-Rice, Rizzo RN, Caisson MD (1995) Eleven years of community-based directly observed therapy for tuberculosis. JAMA 274: 945–951

    Article  PubMed  CAS  Google Scholar 

  13. Centers for Disease Control and Prevention (1998) Tuberculosis morbidity-United States, 1997. MMWR Morb Mortal Rep 47: 253–257

    Google Scholar 

  14. Bayer R, Wilkinson D (1995) Directly observed therapy for tuberculosis: history of an idea. Lancet 345: 1545–1548

    Article  PubMed  CAS  Google Scholar 

  15. Daley CL, Small PM, Schecter GF, et al (1992) An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragmentlength polymorphisms. N Engl J Med 326: 231–235

    PubMed  CAS  Google Scholar 

  16. Selwyn PA, Hartel D, Lewis VA, et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320: 545–550

    PubMed  CAS  Google Scholar 

  17. Asch SM, London AS, Barnes PF, et al (1997) Testing for human immunodeficiency virus infection among tuberculosis patients in Los Angeles. Am J Respir Crit Care Med 155: 378–381

    PubMed  CAS  Google Scholar 

  18. Markowitz N, Hansen NI, Hopewell PC, et al (1997) Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med 126: 123–132

    PubMed  CAS  Google Scholar 

  19. Moreno S, Baraia-Etxaburu J, Bouza E, et al (1993) Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 119: 194–198

    PubMed  CAS  Google Scholar 

  20. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE (1992) High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy, JAMA 268: 504–509

    Article  PubMed  CAS  Google Scholar 

  21. Melnick SL, Sherer R, Louis TA, et al (1994) Survival and disease progression according to gender of patients with HIV. The Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 272: 1915–1921

    Article  PubMed  CAS  Google Scholar 

  22. Graham NM, Cohn S, Galai N, Astemborski J, Nelson KE, Vlahov D (1993) Incidence of mycobacterial infection and disease in HIV-positive and HIV-negative IDUs [Abstract]. Int Conf AIDS 9: 328

    Google Scholar 

  23. Snyder DC, Mohle-Boetani JC, Chandler A, Oliver G, Livermore T, Royce S (1997) A population-based study determining the incidence of tuberculosis attributable to HIV infection. JAIDS 16: 190–194

    PubMed  CAS  Google Scholar 

  24. Mueller G, Whitman S Plummer C (1995) Co-incidence of HIV/AIDS and tuberculosis-Chicago, 1982–1999. MMWR Morb Mortal Rep 44: 227–228

    Google Scholar 

  25. Onorato I, McCombs S, Morgan WM, McGray E (1993) HIV infection in patients attending tuberculosis clinics, United States, 1988–1992 [abstract]. Program and abstracts, 33rd International Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology. Washington DC, p 1363

  26. Sotir MJ, Parrott P, Metchok B, Bock NN, McGowan JE Jr, Ray SM, Miller LP, Blumberg HM (1999) Tuberculosis in the inner city: impact of a continuing epidemic in the 1990s. Clin Infect Dis 29: 1138–1144

    Article  PubMed  CAS  Google Scholar 

  27. Lurie MB (1942) Studies on the mechanism of the immunity in tuberculosis: the fate of tubercle bacilli ingested by mononuclear phagocytes derived from normal and immunized animals. J Exp Med 75: 247–267

    Article  Google Scholar 

  28. Mackaness MB (1969) The influence of immunologically committed lymphoid cells on macrophage activityin vivo. J Exp Med 129: 973–991

    Article  PubMed  CAS  Google Scholar 

  29. Kaufmann SHE (1989) In vitro analysis of the cellular mechanisms involved in immunity to tuberculosis. Rev Infect Dis 2 [Suppl 2]: S448–454

    Google Scholar 

  30. Flesch I, Kaufmann SHE (1987) Mycobacterial growth inhibition by interferon-gamma activated bone marrow macrophages and differential susceptibility among strains ofM. tuberculosis. J Immunol 138: 4408–4413

    PubMed  CAS  Google Scholar 

  31. Newport MJ, Huxley CM, Huston S, et al (1996) A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335: 1941–1949

    Article  PubMed  CAS  Google Scholar 

  32. Rook GA, Steele J, Fraher, et al (1986) Vitamin D, gamma interferon and control of proliferation of M. tuberculosis by human monocytes. Immunol 57: 159–163

    CAS  Google Scholar 

  33. Janis EM, Kaufman SHE, Sheartz RH, Pardoll DM (1989) Activation of gamma/delta T cells in the primary immune response toM. tuberculosis. Science 244: 713–715

    Article  PubMed  CAS  Google Scholar 

  34. Flesch EA, Kaufmann SHE (1988) Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages. Infect Immun 56: 1464–1469

    PubMed  CAS  Google Scholar 

  35. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF (1994) T-cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 94: 2435–2442

    Article  PubMed  CAS  Google Scholar 

  36. Havlir DV, Barnes PF (1999) Tuberculosis in patients with human immunodeficiency virus infection 340: 367–373

    CAS  Google Scholar 

  37. Spear GT, Kessler HA, Rothberg L, Phair J, Landay AL (1990) Decreased oxidative burst activity of monocytes from asymptomatic HIV-infected individuals. Clin Immunol Immunopathol 54: 184–191

    Article  PubMed  CAS  Google Scholar 

  38. Smith PD, Ohura K, Masur H, Lane HC, Fauci AS, Wahl SM (1984) Monocyte function in the acquired immune deficiency syndrome. J Clin Invest 74: 2121–2128

    Article  PubMed  CAS  Google Scholar 

  39. Wahl SM, Allen JB, Gartner S, et al (1989) HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol 142: 3553–3559

    PubMed  CAS  Google Scholar 

  40. Barnes PF, Bloch AB, Davidson PT (1991) Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 324: 1644–1650

    PubMed  CAS  Google Scholar 

  41. Nunn P, Brindle R, Capenter L (1992) Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Am Rev Respir Dis 146: 849–854

    PubMed  CAS  Google Scholar 

  42. Stoneburner R, Laroche E, Prevots R (1992) Survival in a cohort of human immunodeficiency virus infected tuberculosis patients in New York City. Arch Intern Med 152: 2033–2037

    Article  PubMed  CAS  Google Scholar 

  43. Whalen CC, Horsburgh R, Hom D, Lahart M, Ellner J (1995) Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 151: 129–135

    PubMed  CAS  Google Scholar 

  44. Goletti D, Weisman R, Jackson W, et al (1996) Effect ofMycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol 157: 1271–1278

    PubMed  CAS  Google Scholar 

  45. Zhang Y, Broser M, Rom WN (1994) Activation of the interleukin-6-gene byMycobacterium tuberculosis or lipopoly saccharide is mediated by NF-IL6 and NF-ϰB. Proc Natl Acad Sci USA 91: 2225–2229

    Article  PubMed  CAS  Google Scholar 

  46. Zhang Y, Rom WN (1993) Regulation of the interleukin-1β gene by mycobacterial components and lipopolysacharide is mediated by two NF-IL6-like motifs. Mol Cell Biol 13: 3831–3837

    PubMed  CAS  Google Scholar 

  47. Duh E, Maury W, Folks T, Fauci A, Rabson A (1989) Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding on the NF-ϰB sites in the long terminal repeat. Proc Natl Acad Sci USA 86: 5974–5978

    Article  PubMed  CAS  Google Scholar 

  48. Bernstein MS, Tong-Starksen SE, Locksley RM (1991) Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication at the level of gene expression. J Clin Invest 88: 340–545

    Article  Google Scholar 

  49. Goletti A, Kinter P, Biswas P, Bende S, Poli G, Fauci A (1995) Effects of cellular differentiation on cytokine-induced expression on human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression. J Virol 69: 2540–2546

    PubMed  CAS  Google Scholar 

  50. Rich E, Chen I, Zack J, Leonard M, O’Brien W (1992) Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1. J Clin Invest 89: 176–183

    Article  PubMed  CAS  Google Scholar 

  51. Shattock R, Friedland J, Groffin G (1994) Phagocytosis ofMycobacterium tuberculosis modulates human immunodeficiency virus replication in human monocytic cells. J Gen Virol: 75 849–856

    Article  PubMed  CAS  Google Scholar 

  52. Zhang Y, Nakata K, Weiden M, Rom WN (1995)Mycobacterium tuberculosis enhances HIV-1 replication by transcriptional activation of the long terminal repeat. J Clin Invest 95: 2324–2331

    Article  PubMed  CAS  Google Scholar 

  53. Lederman M, Georges D, Kusner D, Mudido P, Giam C, Toossi Z (1994)Mycobacterium tuberculosis and its purified protein derivative activate expression of human immunodeficiency virus. J Acquir Immun Deficiency Syndrome 7: 727–733

    CAS  Google Scholar 

  54. Garrait V, Cadranel J, Esvant H, et al (1997) Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV. J Immunol 159: 2824–2830

    PubMed  CAS  Google Scholar 

  55. Toossi Z, Nicolacakis K, Xia L, Ferrari NA, Rich EA (1997) Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro. J Acquir Immune Defic Syndr Hum Retrovirol 15: 325–331

    PubMed  CAS  Google Scholar 

  56. Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF (1993) Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 148: 1292–1297

    PubMed  CAS  Google Scholar 

  57. Chaisson RE, Slutkin G (1989) Tuberculosis and human immunodeficiency virus infection. J Infect Dis 159: 96–100

    PubMed  CAS  Google Scholar 

  58. Hopewell PC (1989) Tuberculosis and human immunodeficiency virus infection. Semin Respir Infect 4: 111–122

    PubMed  CAS  Google Scholar 

  59. Pitchenik AE, Fertel D (1992) Tuberculosis and nontuberculous mycobacterial disease. Med Clin North Am 76: 121–171

    PubMed  CAS  Google Scholar 

  60. De Cock KM, Soro B, Coulibaly IM, Lucas SB (1992) Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 268: 1581–1587

    Article  PubMed  Google Scholar 

  61. Pitchenik AE, Burr J, Suarez M, Fertel D, Gonzalez G, Moas C (1987) Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. A prospective study. Am Rev Respir Dis 135: 875–879

    PubMed  CAS  Google Scholar 

  62. Theuer CP, Hopewell PC, Elias D, Schecter GF, Rutherford G, Chaisson RE (1990) Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 162: 8–12

    PubMed  CAS  Google Scholar 

  63. Rieder HL, Cauthen GM, Bloch AB, et al (1989) Tuberculosis and acquired immunodeficiency syndrome — Florida. Arch Intern Med 149: 1268–1273

    Article  PubMed  CAS  Google Scholar 

  64. Long R, Scalcini M, Manfreda J, et al (1991) Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti. Am Rev Respir Dis 143: 69–73

    PubMed  CAS  Google Scholar 

  65. Tsicopoulos A, Hamid Q, Varney V, et al (1992) Preferential messenger RNA expression of Thl-type cells (IFN-γ+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol 148: 2058–2061

    PubMed  CAS  Google Scholar 

  66. Fee MJ, Oo MM, Gabayan AE, Radin DR, Barnes PF (1995) Abdominal tuberculosis in patients infected with the human immunodeficiency virus. Clin Infect Dis 20: 938–944

    PubMed  CAS  Google Scholar 

  67. Dube MP, Holtom PD, Larsen RA (1992) Tuberculosis meningitis in patients with and without human immunodeficiency virus infection. Am J Med 93: 520–524

    Article  PubMed  CAS  Google Scholar 

  68. Chaisson RE, Schecter GF, Theuer ChP, Rutherford GW, Echenberg DF, Hopewell PC (1987) Tuberculosis in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 136: 570–574

    PubMed  CAS  Google Scholar 

  69. Pitchenik AE, Rubinson HA (1985) The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 131: 393–396

    PubMed  CAS  Google Scholar 

  70. Louie E, Rice LB, Holzman RS (1986) Tuberculosis in non-Haitian patients with acquired immunodeficiency syndrome. Chest 90: 542–545

    Article  PubMed  CAS  Google Scholar 

  71. Batungwanayo J, Taelman H, Dhote R, Bogaerts J, Allen S, Van De Perre P (1992) Pulmonary tuberculosis in Kigali, Rwanda: impact of human immunodeficiency virus infection on clinical and radiographic presentation. Am Rev Respir Dis 146: 53–56

    PubMed  CAS  Google Scholar 

  72. Shafer RW, Chirgwin KD, Glatt AE, Dahdouh MA, Landesman SH, Suster B (1991) HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS 5: 399–405

    Article  PubMed  CAS  Google Scholar 

  73. Barnes PF, Leedom JM, Chan SF, et al (1988) Predictors of short-term prognosis in patients with pulmonary tuberculosis. J Infect Dis 158: 366–371

    PubMed  CAS  Google Scholar 

  74. Alland D, Kalkut GE, Moss AR, et al (1994) Transmission of tuberculosis in New York City: an analysis of DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 330: 1710–1716

    Article  PubMed  CAS  Google Scholar 

  75. Small PM, Hopewell PC, Signh SP, et al (1994) The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 330: 1703–1709

    Article  PubMed  CAS  Google Scholar 

  76. Daley CL (1995) The typically ‘atypical’ radiographic presentation of tuberculosis in advanced HIV disease [editorial]. Tuber Lung Dis 76: 475–476

    Article  PubMed  CAS  Google Scholar 

  77. Perlman DC, El-Sadr WM, Nelson TE, et al (1997) Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. Clin Infect Dis 25: 242–246

    Article  PubMed  CAS  Google Scholar 

  78. Mukadi Y, Perriëns JH, Louis ME, et al (1993) Spectrum of immunodeficiency in HIV-I-infected patients with pulmonary tuberculosis in Zaire. Lancet 342: 143–146

    Article  PubMed  CAS  Google Scholar 

  79. Pastores SM, Naidich DP, Aranda CP, McGuinnes G, Rom WN (1993) Intrathoracic adenopathy associated with pulmonary tuberculosis in patients with human immunodeficiency virus infection. Chest 103: 1433–1437

    Article  PubMed  CAS  Google Scholar 

  80. Keiper MD, Beumont M, Elshami A, Langlotz CP, Miller WT Jr (1995) CD-T lymphocyte count and the radiographic presentation of pulmonary tuberculosis: a study of the relationship between these factors in patients with human immunodeficiency virus infection. Chest 107: 74–80

    Article  PubMed  CAS  Google Scholar 

  81. Post FA, Wood R, Pillay GP (1995) Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-Lymphocyte count. Tubercle Lung Dis 76: 518–521

    Article  CAS  Google Scholar 

  82. Levy H, Feldman C, Sacho H, van der Meulen H, Kallenbach J, Koornhof H (1989) A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis. Chest 95: 1193–1197

    Article  PubMed  CAS  Google Scholar 

  83. Gordin F, Slutkin G (1990) The validity of acid-fast smears in the diagnosis of pulmonary tuberculosis. Arch Pathol Lab Med 114: 1025–1027

    PubMed  CAS  Google Scholar 

  84. Kramer F, Modilevsky T, Waliany A, Leedom J, Barnes P (1990) Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med 89: 451–456

    Article  PubMed  CAS  Google Scholar 

  85. Greenbaum M, Beyt BE, Murray PR (1980) The accuracy of diagnosing tuberculosis at a large teaching hospital. Am Rev Respir Dis 121: 477–481

    PubMed  CAS  Google Scholar 

  86. Klein N, Duncanson F, Lenox T, Pitta A, Cohen S, Wornser G (1989) Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest 95: 190–192

    Article  Google Scholar 

  87. Middlebrook G, Reggiardo Z, Tigert WD (1977) Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. Am Rev Respir Dis 115: 1066–1071

    PubMed  CAS  Google Scholar 

  88. Aliyu MH, Salihu HM (2003) HIV infection and Sputum-culture conversion in patients diagnosed withMycobacterium tuberculosis: a population-based study. Wien Klin Wochenschr 115: 340–346

    Article  PubMed  Google Scholar 

  89. Kennedy DJ, Lewis WP, Barnes PJ (1992) Yield of bronchoscopy for the diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Chest 102: 1040–1044

    Article  PubMed  CAS  Google Scholar 

  90. Steele BA, Daniel TM (1991) Evaluation of the potential role of serodiagnosis of tuberculosis in a clinic in Bolivia by decision analysis, Am Rev Respir Dis 143: 713–716

    PubMed  CAS  Google Scholar 

  91. Eisenstein BI (1990) The polymerase chain reaction: a new diagnostic method of using molecular genetics for medical diagnosis. N Engl J Med 322: 178–183

    PubMed  CAS  Google Scholar 

  92. Thierry D, Brisson-Noel A, Vincent-Levy-Frebault V, Nguyen D, Guesdon JL, Gicquet B (1990) Characterisation of aMycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis. J Clin Microbiol 28: 2668–2673

    PubMed  CAS  Google Scholar 

  93. Catanzaro A, Davidson BL, Fujiwara PI, et al (1997) Rapid diagnostic tests for tuberculosis: what is the appropriate use? Am J Respir Crit Care Med 155: 1804–1814

    Google Scholar 

  94. Wilson S, McNerney R, Nye P, Godfrey-Faussett Stoker N, Voller A (1993) Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. J Clin Microbiol 31: 776–782

    PubMed  CAS  Google Scholar 

  95. Shanker P, Manjunath N, Mohan KK, Prasad K, Behari SM, Ahula GK (1991) Rapid diagnosis of tuberculosis meningitis by polymerase chain reaction. Lancet 337: 5–7

    Article  Google Scholar 

  96. Brindle R, Nunn PP, Githui W, Allen BW, Gathua S, Waiyaki P (1993) Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis 147: 958–961

    PubMed  CAS  Google Scholar 

  97. Chaisson RE, Clemont HC, Holt EA, et al (1996) Sixmonth supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection. Am J Respir Crit Care Med 1154: 1034–1038

    Google Scholar 

  98. Perriëns JH, St Louis ME, Mukadi YB, et al (1995) Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months. N Engl J Med 332: 779–784

    Article  PubMed  Google Scholar 

  99. Pulido F, Pena J-M, Rubio R, et al (1997) Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients. Arch Intern Med 157: 227–232

    Article  PubMed  CAS  Google Scholar 

  100. Hammer SM, Squires KE, Hughes MD, et al (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 337: 725–733

    Article  PubMed  CAS  Google Scholar 

  101. Molla A, Korneyeva M, Gao Q, et al (1996) Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat Med 2: 760–766

    Article  PubMed  CAS  Google Scholar 

  102. Havlir D, Cheeseman SH, McLaughlin M, et al (1995) High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis 171: 537–545

    PubMed  CAS  Google Scholar 

  103. Munsiff SS, Joseph S, Ebrahimzadeh A, Frieden TR (1997) Rifampicin-monoresistant tuberculosis in New York City, 1993–1994. Clin Infect Dis 25: 1465–1467

    Article  PubMed  CAS  Google Scholar 

  104. Lutfey M, Della-Latta P, Kapur V, et al (1996) Independent origin of mono-rifampin-resistant My cobacterium tuberculosis in patients with AIDS. Am J Respir Crit Care Med 153: 837–840

    PubMed  CAS  Google Scholar 

  105. Ridzon R, Whitney CG, McKenna MT, et al (1998) Risk factors for rifampicin mono-resistant tuberculosis. Am J Respir Crit Care Med 157: 1881–1884

    PubMed  CAS  Google Scholar 

  106. Peloquin CA, Nitta AT, Burman WJ, et al (1996) Low antituberculosis drug concentrations in patients with AIDS. Ann Pharmacother 30: 919–925

    PubMed  CAS  Google Scholar 

  107. Barditch-Crovo P (1999) The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clin Pharmacol Ther 65: 428–438

    Article  PubMed  CAS  Google Scholar 

  108. Blaschke TF, Skinner MH (1996) The clinical pharmacokinetics of rifabutin. Clin Infect Dis 22 [Suppl 1]: S15–21

    Google Scholar 

  109. Hamzeh FM, Benson C, Gerber J, et al (2003) Steadystate pharmacokinetic interaction of modified-dose indinavir and rifabutin. Clin Pharmacol Ther 73: 159–169

    Article  PubMed  CAS  Google Scholar 

  110. Choudhri SH, Hawken M, Gathua S, et al (1997) Pharcokinetics of anti-mycobacterial drugs in patients with tuberculosis. AIDS, and diarrhea. Clin Infect Dis 25: 104–111

    Article  PubMed  CAS  Google Scholar 

  111. Ackah AN, Coulibaly D, Digbeu H, et al (1995) Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d’lvoire. Lancet 345: 607–610

    Article  PubMed  CAS  Google Scholar 

  112. Chien JW, Johnson JL (1998) Paradoxical reactions in HIV and pulmonary TB. Chest 114: 933–936

    Article  PubMed  CAS  Google Scholar 

  113. Wendel KA, Alwood KS, Gachuhi R, et al (2001) Paradoxical worsening of Tuberculosis in HIV-infected persons.Chest 120: 193–197

    Article  PubMed  CAS  Google Scholar 

  114. Narita M, Ashkin D, Hollender ES, et al (1998) Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158: 157–161

    PubMed  CAS  Google Scholar 

  115. Nunn P, Brindle L, Carpenter J, et al (1992) Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya: analysis of early (six-month) mortality. Am Rev Respir Dis 146: 849–854

    PubMed  CAS  Google Scholar 

  116. Whalen C, Okwera A, Johnson J, et al (1996) Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. Am J Respir Crit Care Med 153: 1977–1981

    PubMed  CAS  Google Scholar 

  117. Pablos-Méndez A, Sterling TR, Frieden TR (1996) The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 276: 1223–1228

    Article  PubMed  Google Scholar 

  118. Perriëns JH, Colebunders RL, Karahunga C, et al (1991) Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with “standard” chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis 144: 750–755

    PubMed  Google Scholar 

  119. Richter C, Koelemay MJW, Swai ABM, Perenboom R, Mwakyusa DH, Oosting J (1995) Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis. Tubercle and Lung Dis 76: 510–517

    Article  CAS  Google Scholar 

  120. Whalen C, Horsburgh R, Hom D, Lahart C, Simberkoff M, Ellner J (1995) Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 151: 129–135

    PubMed  CAS  Google Scholar 

  121. Whalen C, Horsburgh R, Hom D, Lahart C, Simberkoff M, Ellner J (1997) Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS 11: 455–460

    Article  PubMed  CAS  Google Scholar 

  122. Connolly C, Reid A, Davies G, Sturm W, McAdam KP, Wilkinson D (1999) Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa. AIDS 13: 1543–1547

    Article  PubMed  CAS  Google Scholar 

  123. Murray J, Sonnenberg P, Shearer SC, Godfrey-Faussett P (1999) Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Care Med 159: 733–740

    CAS  Google Scholar 

  124. Whalen CC, Nsubuga P, Okwera A, et al (2000) Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 14: 1219–1228

    Article  PubMed  CAS  Google Scholar 

  125. Jones BE, Otaya M, Antoniskis D, et al (1994) A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection. Am J Respir Crit Care Med 150: 1499–1502

    PubMed  CAS  Google Scholar 

  126. Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA (1993) Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type I. J Exp Med 177: 1511–1516

    Article  PubMed  CAS  Google Scholar 

  127. Valone SE, Rich EA, Wallis RS, Ellner JJ (1988) Expression of tumor necrosis factor in vitro by human mononnuclear phagocytes stimulated with whole Mycobacterium bovis BCG and Mycobacterial antigens. Infect Immunol 56: 3313–3315

    CAS  Google Scholar 

  128. Barnes PF, Fong S-J, Brennan PJ, Twomey PE, Mazumder A, Modlin RL (1990) Local production of tumor necrosis factor and interferong in tuberculous pleuritis. J Immunol 145: 149–154

    PubMed  CAS  Google Scholar 

  129. Matsuyama T, Kobayashi N, Yamamoto N (1991) Cytokines and HIV infection: is AIDS a tumor necrosis factor disease. AIDS 5: 1405–1417

    Article  PubMed  CAS  Google Scholar 

  130. Munsiff SS, Alpert PL, Gourevitch MN, Chang CJ, Klein RS (1998) A prospective study of tuberculosis and HIV disease progression. JAIDS 19: 361–366

    PubMed  CAS  Google Scholar 

  131. Dannenburg AM (1991) Delayed hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 12: 228–233

    Article  Google Scholar 

  132. Markowitz N, Hansen NI, Wilcosky TC, et al (1993) Tuberculi and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med 119: 185–193

    PubMed  CAS  Google Scholar 

  133. Shafer RW, Kim DS, Weiss JP, Quale JM (1991) Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine 70: 384–397

    Article  PubMed  CAS  Google Scholar 

  134. Berenguer J, Moreno S, Laguna F, et al (1992) Tuberculosis meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 326: 668–672

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hamisu M. Salihu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aliyu, M.H., Salihu, H.M. Tuberculosis and HIV disease: Two decades of a dual epidemic. Wien Klin Wochenschr 115, 685–697 (2003). https://doi.org/10.1007/BF03040884

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03040884

Key words

Navigation